ICA-264

N/A

Report date: 2025/06/11 10:41:42

NME

Base Information

Drug NameICA-264

Drug Alias NameN/A

ClassificationSmall molecules

Mechanisms of ActionApolipoprotein L1 inhibitors

TargetsApolipoprotein L1

Therapy Area/IndicationsProteinuria

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesOmniAb Inc

China Registration ClassN/A

Develop Information

Active CompaniesOmniAb Inc

Inactive CompaniesN/A

Active IndicationsProteinuria

Inactive IndicationsN/A

Other Information

ATC CodeN/A

Related LinksN/A